Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of TG Therapeutics, Inc. Investors

November 13, 2018

BENSALEM, Pa.--(BUSINESS WIRE)--Nov 13, 2018--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased TG Therapeutics, Inc. (“TG Therapeutics” or the “Company”) (NASDAQ: TGTX ) securities between June 4, 2018 and September 25, 2018,  inclusive (the “Class Period”). TG Therapeutics investors have until  December 3, 2018 to file a lead plaintiff motion.

Investors suffering losses on their TG Therapeutics investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.

On September 26, 2018, TG Therapeutics announced that it could not proceed with the interim analysis of one of its leading product candidates, Ublituximab (TG-1101), following a determination by the FDA Data Safety Monitoring Board trials, that the UNITY-CLL trial data was not mature enough to continue. On this news, TG Therapeutics dropped 44% to close at $5.15 per share, thereby injuring investors.

The complaint filed in this class action alleges that the Company made false and misleading statements to the market. TG Therapeutics was engaged in cleaning the data collected from its UNITY-CLL study, which gave it an understanding of the efficacy of the combination therapy. Based on that understanding, the Company knew the study had failed to reach its goals, and therefore knew it would not be able to seek accelerated approval. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period.

If you purchased shares of TG Therapeutics, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181113006236/en/

CONTACT: Law Offices of Howard G. Smith

Howard G. Smith, Esquire







SOURCE: Law Offices of Howard G. Smith

Copyright Business Wire 2018.

PUB: 11/13/2018 05:45 PM/DISC: 11/13/2018 05:45 PM


Update hourly